Nengqian Ma

Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5

Li-qin Chao, Baolai Zhang, Xue Chen, 2017, Toxicology and applied pharmacology.

Association between SII and hepatic steatosis and liver fibrosis: A population-based study

Nengqian Ma, Qianlong Liu, Lihong Li, 2022, Frontiers in Immunology.

Diverse roles of UBE2T in cancer (Review)

Nengqian Ma, Zhang-Yi Li, Xian-zhou Lu, 2023, Oncology reports.

Saturation Effect of Body Mass Index on Bone Mineral Density in Adolescents of Different Ages: A Population-Based Study

Xiangjun Xiao, Nengqian Ma, Xiongjie Huang, 2022, Frontiers in Endocrinology.

Arginine methyltransferase inhibitor 1 exhibits antitumor effects against cervical cancer in vitro and in vivo.

Baolai Zhang, Xinyang Zhang, Nengqian Ma, 2018, Die Pharmazie.